Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01
-
Shares outstanding
-
89.3M
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
10.6M
-
Shares change
-
-239K
-
Total reported value, excl. options
-
$35.1M
-
Value change
-
-$4.13M
-
Number of buys
-
16
-
Number of sells
-
-14
-
Price
-
$3.30
Significant Holders of COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 (CGEN) as of Q2 2018
42 filings reported holding CGEN - COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 as of Q2 2018.
COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 (CGEN) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.6M shares
of 89.3M outstanding shares and own 11.9% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (5.37M shares), Rock Springs Capital Management LP (1.08M shares), MORGAN STANLEY (971K shares), GREAT POINT PARTNERS LLC (759K shares), Taylor Frigon Capital Management LLC (666K shares), ROTHSCHILD INVESTMENT CORP /IL (415K shares), UBS Group AG (268K shares), RENAISSANCE TECHNOLOGIES LLC (245K shares), BENJAMIN F. EDWARDS & COMPANY, INC. (168K shares), and MATRIX ASSET ADVISORS INC/NY (86.5K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.